Compare NBTB & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTB | PRGO |
|---|---|---|
| Founded | 1856 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.8B |
| IPO Year | N/A | 1991 |
| Metric | NBTB | PRGO |
|---|---|---|
| Price | $41.88 | $13.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $52.33 | $22.50 |
| AVG Volume (30 Days) | 208.6K | ★ 4.0M |
| Earning Date | 10-27-2025 | 11-05-2025 |
| Dividend Yield | 3.53% | ★ 8.63% |
| EPS Growth | ★ 5.89 | N/A |
| EPS | ★ 3.02 | N/A |
| Revenue | $629,728,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $27.08 | N/A |
| Revenue Next Year | $9.17 | N/A |
| P/E Ratio | $13.89 | ★ N/A |
| Revenue Growth | ★ 16.88 | N/A |
| 52 Week Low | $37.31 | $12.17 |
| 52 Week High | $52.44 | $30.93 |
| Indicator | NBTB | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.23 | 32.48 |
| Support Level | $40.80 | $13.34 |
| Resistance Level | $42.58 | $14.12 |
| Average True Range (ATR) | 0.97 | 0.47 |
| MACD | 0.12 | 0.34 |
| Stochastic Oscillator | 71.45 | 66.41 |
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.